An Aerts

Person

Aerts, An

Person

  1. Gold nanoparticles meet medical radionuclides

    Daems, N., Michiels, C., Lucas, S., Baatout, S. & Aerts, A., 1 Sep 2021, In: Nuclear Medicine and Biology. 100-101, p. 61-90 30 p.

    Research output: Contribution to journalArticlepeer-review

  2. Radiolabeling of Gold Nanoparticles With Lu-177 as a Platform for Cancer Theranostics

    Daems, N., Ooms, M., Cardinaels, T., Baatout, S., Michiels, C., Lucas, S. & Aerts, A., 31 Dec 2019, Annual Congress of the European Association of Nuclear Medicine October 12 – 16, 2019 Barcelona, Spain. S1 ed. Vol. 46. p. S752 1 p. (European Journal of Nuclear Medicine and Molecular Imaging).

    Research output: Contribution to report/book/conference proceedingsIn-proceedings paperpeer-review

  3. Quantitative analysis of radiation-induced senescence in endothelial cells

    De Ridder, L., Baselet, B. & Aerts, A., 9 Jan 2017, 17 p.

    Research output: ThesisMaster's thesis

  4. Calcium, oxidative stress and connexin channels, a harmonious orchestra directing the response to radiotherapy treatment?

    Decrock, E., Hoorelbeke, D., Ramadan, R., Delvaeye, T., De Bock, M., Wang, N., Krysko, D. V., Baatout, S., Bultynck, G., Aerts, A., Vinken, M. & Leybaert, L., 1 Jun 2017, In: Biochimica et Biophysica Acta . 1864, 6, p. 1099-1120 21 p.

    Research output: Contribution to journalLiterature reviewpeer-review

  5. Antioxidants: A new approach to tackle radiation-induced cancers

    Derradji, H., Abouelaradat, K., Aerts, A., Faraj Akram, K., Baatout, S. & Harakeh, S., 26 Nov 2009, HERBAL MEDICINE: A Cancer Chemopreventive and Therapeutic perspective. 1 ed. New delhi, India: Jaypee Brothers Medical Publishers, p. 441-472

    Research output: Contribution to report/book/conference proceedingsChapterpeer-review

  6. Chapter 35: Molecular Imaging Using Nanobodies: A Case Study

    Devoogdt, N., Xavier, C., Hernot, S., Vaneycken, I., D'huyvetter, M., De Vos, J., Massa, S., De Baetselier, P., Caveliers, V., Lahoutte, T., Impens, N., Aerts, A. & Baatout, S., Jan 2012, Singe Domain Antibodies, Methods and Protocols. 1 ed. Springer New York Heidelberg Dordrecht London, United States: Springer, p. 559-567 (Methods in Molecular Biology; no. 911).

    Research output: Contribution to report/book/conference proceedingsChapterpeer-review

  7. Targeted Radionuclide Therapy with A 177Lu-labeled Anti-HER2 Nanobody

    D'huyvetter, M., Vincke, C., Xavier, C., Aerts, A., Impens, N., Baatout, S., De Raeve, H., Muyldermans, S., Caveliers, V., Devoogdt, N. & Lahoutte, T., Apr 2014, In: Theranostics. 4, 7, p. 708-720

    Research output: Contribution to journalArticlepeer-review

  8. Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators

    D'huyvetter, M., Aerts, A., Xavier, C., Vaneycken, I., Devoogdt, N., Gijs, M., Impens, N., Baatout, S., Ponsard, B., Muyldermans, S., Caveliers, V. & Lahoutte, T., Apr 2012, In: Contrast Media & Molecular Imaging. 7, 2, p. 254-264

    Research output: Contribution to journalArticlepeer-review

  9. De rol van intercellulaire communicatie in cardiovasculaire aandoeningen na lage stralingsdosis

    Dobbelaere, H. & Aerts, A., Jun 2015, Ghent, Belgium: UGent - Universiteit Gent. 30 p.

    Research output: ThesisMaster's thesis

  10. Gold nanoparticles coated with antibodies lead to ROSdependent apoptotic cell death in non-cancerous human cell lines

    Fichera, O., Van Hoecke, K., Baatout, S., Cardinaels, T., Michiels, C., Lucas, S. & Aerts, A., 31 Dec 2018, Annual Congress of the European Association of Nuclear Medicine October 13 – 17, 2018 Düsseldorf, Germany. Vol. 45. p. S653 1 p. (European Journal of Nuclear Medicine and Molecular Imaging).

    Research output: Contribution to report/book/conference proceedingsIn-proceedings paperpeer-review

  11. Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumour

    Geenen, L., Nonnekens, J., Konijnenberg, M. W., Baatout, S., de Jong, M. & Aerts, A., 1 Nov 2021, In: Nuclear Medicine and Biology. 102-103, p. 1-11 11 p.

    Research output: Contribution to journalArticlepeer-review

  12. Preclinical development of 698ga-labelled aptamers for molecular cancer imaging

    Gijs, M., Aerts, A., Impens, N. & Baatout, S., 17 Sep 2015, Liège, Belgium: ULg - Université de Liège. 181 p.

    Research output: ThesisDoctoral thesis

  13. Gallium-68-labelled NOTA-oligonucleotides - an optimized method for their preparation

    Gijs, M., Dammicco, S., Warnier, C., Aerts, A., Impens, N., D’Huyvetter, M., Léonard, M., Baatout, S. & Luxen, A., 1 Feb 2016, In: Journal of Labelled Compounds and Radiopharmaceuticals. 59, 2, p. 63-71 9 p.

    Research output: Contribution to journalArticlepeer-review

  14. Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer

    Gijs, M., Penner, G., Blackler, G. B., Impens, N., Baatout, S., Luxen, A. & Aerts, A., 15 May 2016, In: Pharmaceuticals. 9, 2, 29.

    Research output: Contribution to journalArticlepeer-review

  15. Aptamers as radiopharmaceuticals for nuclear imaging and therapy

    Gijs, M., Aerts, A., Impens, N., Baatout, S. & Luxen, A., 15 Apr 2016, In: Nuclear Medicine and Biology.

    Research output: Contribution to journalArticlepeer-review

  16. Biodistribution of Novel 68Ga-Radiolabelled HER2 Aptamers in Mice

    Gijs, M., Becker, G., Plenevaux, A., Bahri, M. A., Aerts, A., Impens, N., Baatout, S. & Luxen, A., 11 Aug 2016, In: Journal of Nuclear Medicine and Radiation Therapy. 7, 5, 8 p., 1000300.

    Research output: Contribution to journalArticlepeer-review

  17. Ionizing radiation biomarkers in epidemiological studies – An update

    Hall, J., Jeggo, P., West, C., Gomolka, M., Quintens, R., Badie, C., Laurent, O., Aerts, A., Anastasov, N., Azimzadeh, O., Azizova, T., Baatout, S., Baselet, B., Benotmane, R., Blanchardon, E., Gueguen, Y., Haghdoost, S., Harms-Ringhdahl, M., Hess, J., Kreuzer, M., Laurier, D., Macaeva, E., Manning, G., Pernot, E., Ravanat, J-L., Sabatier, L., Tack, K., Tapio, S., Zitzelsberger, H. & Cardis, E., 16 Jan 2017, In: Mutation Research/Reviews in Mutation Research. 771, p. 59-84 26 p.

    Research output: Contribution to journalArticlepeer-review

  18. The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so far

    Heynickx, N., Herrmann, K., Vermeulen, K., Baatout, S. & Aerts, A., 2021, In: Nuclear Medicine and Biology. 98-99, p. 30-39 10 p.

    Research output: Contribution to journalArticlepeer-review

  19. PRECLINICAL RESEARCH AND SYSTEMATIC PRODUCTION OF INNOVATIVE MEDICAL RADIO-ISOTOPES AT ISOL@MYRRHA

    Popescu, L., Pauwels, D., Aerts, A., Aït Abderrahim, H., Baatout, S., Baeten, P., Gijs, M., Huyse, M., Impens, N., Neyens, G., Raabe, R., Severijns, N., Schuurmans, P., Schyns, M., Temst, K., Van Duppen, P., Vantomme, A. & Wagemans, J., Mar 2012, In: Radiotherapy & Oncology Journal. 102, 1, p. 111-111

    Research output: Contribution to journalArticlepeer-review

ID: 39219